Hamilton Thorne Ltd (CVE:HTL) – Equities research analysts at Zacks Investment Research dropped their FY2018 earnings per share estimates for Hamilton Thorne in a research note issued on Tuesday. Zacks Investment Research analyst A. Dushyanth now forecasts that the company will post earnings of $0.02 per share for the year, down from their prior forecast of $0.03.

COPYRIGHT VIOLATION WARNING: “FY2018 EPS Estimates for Hamilton Thorne Ltd Lowered by Zacks Investment Research (HTL)” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.watchlistnews.com/fy2018-eps-estimates-for-hamilton-thorne-ltd-lowered-by-zacks-investment-research-htl/1536396.html.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products.

Receive News & Ratings for Hamilton Thorne Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.